Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Study: Gilead's ($GILD) Truvada cuts HIV risk 44%
Study: Gilead's ($GILD) Truvada cuts HIV risk 44%
Study: Gilead's ($GILD) Truvada cuts HIV risk 44%
Submitted by
admin
on November 23, 2010 - 10:40am
Source:
Fierce Pharma
News Tags:
Gilead Sciences
Truvada
HIV
Headline:
Study: Gilead's ($GILD) Truvada cuts HIV risk 44%
Do Not Allow Advertisers to Use My Personal information
